We are demo-ing PathChat 1 in booth #8 at #cvpr! From now to 6:00 PM today in Arch 4B (next to the exhibition, section 2100), come see PathChat in action! #pathology #histology #ai
Richard J. Chen’s Post
More Relevant Posts
-
Coming out of stealth, I am excited to announce that I am joining Modella AI as the Founding CTO! We are pioneering generative, multimodal, and agentic AI for diagnostic, prognostic, and therapeutic workflows. With Faisal Mahmood + Ming Yang (Max) Lu throughout my PhD, we have released several amazing foundation models (UNI, CONCH, and most recently PathChat published @ Nature: https://lnkd.in/eNm2Ax-V). Now, we are going all the way to translate these models for clinical and research use. See our announcement below, and join our waitlist for PathChat 2 at https://modella.ai. Congratulations to the entire team: Jill Stefanelli, Faisal Mahmood, Ming Yang (Max) Lu, Long Phi Le, Bowen Chen, Kuan Chen, Ming Yang, and everyone else. Stay tuned for more exciting announcements!
🚀 We’re thrilled to come out of stealth and announce PathChat 2, the first multimodal generative AI copilot for human pathology. PathChat 2 is designed to transform pathology by enabling pathologists, trainees, and researchers to leverage the power of generative AI. With the ability to analyze and reason over both pathology images and text, PathChat 2 works with whole-slide images, microscopes, and smartphones - delivering region-level and slide-level morphological analysis and interactive consultation. Compared to its predecessor, PathChat 1 (recently published in Nature, https://lnkd.in/ea8SmfgV), PathChat 2 boasts substantial improvements in differential diagnosis, morphological description, and is more adept at diverse tasks such as open-ended question answering and slide-level summarization. Follow us on X, https://x.com/modella_ai, to stay up to date. Sign up for our waitlist, and discover more at https://www.modella.ai. Faisal Mahmood Jill Stefanelli Long Phi Le Richard J. Chen Ming Yang (Max) Lu Kuan Chen Bowen Chen Zahra Noor Farhan Mahmood Ming Yang
-
Excited to announce (* 4 months late 😅) that I have passed my PhD defense! Crossing this finish line would not be possible without the support and collaboration of many colleagues and mentors, and also without Faisal Mahmood! With Faisal Mahmood, Guillaume Jaume, Andrew H. Song, Anurag Vaidya, Ming Yang (Max) Lu, Tong Ding, Bowen Chen, Drew Williamson (and the rest of the lab), I'm also excited to share our latest progress on building and evaluating pathology foundation models (from ROIs to the whole-slide) in Nature Medicine 2024 and CVPR 2024! The culmination of all of the work completed during my PhD 😎. The blog post below serves to summarize our progress, insights, and outlook of several research articles: 1. UNI, Nature Med 2024: https://rdcu.be/dBMgh 2. CONCH, Nature Med 2024: https://rdcu.be/dBMf6 3. Demographic Biases in CPath, Nature Med 2024: https://rdcu.be/dFdMS 4. TANGLE, CVPR 2024: https://lnkd.in/e9HCtEEw 5. PANTHER, CVPR 2024: https://lnkd.in/eEAcbvj7 At CVPR 2024, also check out our poster on multimodal integration between histopathology and transcriptomic pathways via SurvPath (https://lnkd.in/efvt4hDm), keynote at the Workshop on Foundation Models in Medical Vision (https://lnkd.in/e7sstATD), Demos for TriPath (https://lnkd.in/egkcNbjR) and PathChat, and several posters at the CV4Science workshops (https://lnkd.in/eimFBCyM). It would be awesome to finally start meeting many of the faces working on pathology foundation models (there are dozens of us). #cvpr #ai #pathology #computervision #deeplearning * Personal Updates: I have not been as responsive on LinkedIn, as I am just ending my paternity leave after 3 months! His name is Jensen 🤗
Head of Pathology
1wDo you also have an online test platform?